Modified Ileal Conduit for Pelvic Lipomatosis: Technique Description and Outcome.

IF 1.5 4区医学 Q3 UROLOGY & NEPHROLOGY

Urologia Internationalis Pub Date : 2024-01-01 Epub Date: 2024-03-21 DOI:10.1159/000538369

Mancheng Xia, Chang Meng, Peng Zhang, Xiaohui Tan, Yuke Chen, Jian Fan, Zhihua Li, Bing Wang, Hongjian Zhu, Kunlin Yang, Liqun Zhou, Ninghan Feng, Kai Zhang, Xuesong Li

{"title":"Modified Ileal Conduit for Pelvic Lipomatosis: Technique Description and Outcome.","authors":"Mancheng Xia, Chang Meng, Peng Zhang, Xiaohui Tan, Yuke Chen, Jian Fan, Zhihua Li, Bing Wang, Hongjian Zhu, Kunlin Yang, Liqun Zhou, Ninghan Feng, Kai Zhang, Xuesong Li","doi":"10.1159/000538369","DOIUrl":null,"url":null,"abstract":"Introduction: The aim of this study was to present the surgical technique and clinical outcomes of modified ileal conduit for pelvic lipomatosis (PL).Methods: From 2020 to 2022, we prospectively enrolled 9 patients with PL undergoing modified ileal conduit. The patient characteristics, perioperative variables, and follow-up outcomes as well as the description of surgical technique were reported.Results: All 9 patients successfully completed the operation. Two patients had perioperative complications of Clavien-Dindo grade I. The mean operation time and bleeding volumes were 253 ± 51.4 min and 238.9 ± 196.9 mL, with a mean postoperative follow-up time of 13.0 ± 5.6 months. The postoperative 3-month and 1-year creatinine values were significantly decreased versus the preoperative (p = 0.006 and p = 0.024). The postoperative 3-month and 1-year estimated glomerular filtration rate values were significantly increased compared with those before operation (p = 0.0002 and p = 0.018). The separation value of left renal pelvis collection system after operation was significantly reduced compared with preoperative evaluation (p = 0.023 at 3 months and p = 0.042 at 1 year) and so was the right side (p = 0.019 and p = 0.023).Conclusion: Modified ileal conduit is safe and feasible for PL. A large sample cohort with long-term follow-up is needed to evaluate the clinical outcomes of PL.","PeriodicalId":23414,"journal":{"name":"Urologia Internationalis","volume":" ","pages":"314-321"},"PeriodicalIF":1.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11305515/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologia Internationalis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000538369","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The aim of this study was to present the surgical technique and clinical outcomes of modified ileal conduit for pelvic lipomatosis (PL).

Methods: From 2020 to 2022, we prospectively enrolled 9 patients with PL undergoing modified ileal conduit. The patient characteristics, perioperative variables, and follow-up outcomes as well as the description of surgical technique were reported.

Results: All 9 patients successfully completed the operation. Two patients had perioperative complications of Clavien-Dindo grade I. The mean operation time and bleeding volumes were 253 ± 51.4 min and 238.9 ± 196.9 mL, with a mean postoperative follow-up time of 13.0 ± 5.6 months. The postoperative 3-month and 1-year creatinine values were significantly decreased versus the preoperative (p = 0.006 and p = 0.024). The postoperative 3-month and 1-year estimated glomerular filtration rate values were significantly increased compared with those before operation (p = 0.0002 and p = 0.018). The separation value of left renal pelvis collection system after operation was significantly reduced compared with preoperative evaluation (p = 0.023 at 3 months and p = 0.042 at 1 year) and so was the right side (p = 0.019 and p = 0.023).

Conclusion: Modified ileal conduit is safe and feasible for PL. A large sample cohort with long-term follow-up is needed to evaluate the clinical outcomes of PL.

查看原文本刊更多论文

改良回肠导管治疗盆腔脂肪瘤病：技术描述与结果

简介：目的介绍改良回肠导管治疗盆腔脂肪瘤（PL）的手术技巧和临床疗效：从2020年到2022年，我们对9例接受改良回肠导管术的盆腔脂肪瘤患者进行了前瞻性研究。结果：9名患者均顺利完成手术：结果：9名患者均顺利完成手术。平均手术时间为（253±51.4）分钟，出血量为（238.9±196.9）毫升，术后平均随访时间为（13.0±5.6）个月。术后 3 个月和 1 年的肌酐值与术前相比明显下降（P=0.006 和 P=0.024）。术后 3 个月和 1 年的 eGFR 值与术前相比明显升高（P=0.0002 和 P=0.018）。与术前相比，术后左肾盂收集系统的分离值明显降低（3个月时P=0.023，1年时P=0.042），右侧也是如此（P=0.019，P=0.023）：结论：改良回肠导管用于PL是安全可行的。结论：改良式回肠导管是一种安全、可行的回肠导管，需要对大量样本进行长期随访，以评估回肠导管的临床效果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Urologia Internationalis 医学-泌尿学与肾脏学

CiteScore

3.30

自引率

6.20%

发文量

审稿时长

3-8 weeks

期刊介绍： Concise but fully substantiated international reports of clinically oriented research into science and current management of urogenital disorders form the nucleus of original as well as basic research papers. These are supplemented by up-to-date reviews by international experts on the state-of-the-art of key topics of clinical urological practice. Essential topics receiving regular coverage include the introduction of new techniques and instrumentation as well as the evaluation of new functional tests and diagnostic methods. Special attention is given to advances in surgical techniques and clinical oncology. The regular publication of selected case reports represents the great variation in urological disease and illustrates treatment solutions in singular cases.